Atypical signaling defects prevent IL-2 gene expression in lpr/lpr CD4- CD8- cells

Journal of Biomedical Science

Volumn 5, Issue 4, 1998, Pages 297-304

  Liang, Hong Erh ^a,b,c   Hsueh, Yi Ping ^a,b   Wu, Chia Cheng ^a,c   Hsu, Shu Ching ^a,c   Han, Shou Hwa ^b   Lai, Ming Zong ^a,b,c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Fas; IL 2 gene expression; JNK; lpr lpr; MAP kinase; Signaling defect; SLE

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0031830012     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/bf02255862     Document Type: Article

References (49)

1. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90:1756-1760;1993.
2. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178: 2231-2235;1993.
3. Altman A, Theofilopoulos AN, Weiner R, Katz DH, Dixon FJ. Analysis of T cell function in autoimmune murine strains: Defects in production and responsiveness to interleukin-2. J Exp Med 1954:791-808;1981.
4. Brorson KA, Beverly B, Kang SM, Lenardo M, Schwartz RH. Transcriptional regulation of cytokine genes in nontransformed T cells: apparent constitutive signals in run-on assays can be caused by repeat sequences. J Immunol 147: 3601-3609;1991.
5. Budd RC, Winslow G, Inokuchi S, Imoden JB. Intact antigen receptor-mediated generation of inositol phosphates and increased imracellular calcium in CD4-CD8- T lymphocytes from MRL lpr mice. J Immunol 145:2862-2872; 1990.
6. + CD4-CD8- T cells in lpr mice. J Immunol 148: 1055-1064;1992.
7. Carrera AC, Rincon M, De Landazuri MO, Lopez-Botet M. CD2 is involved in regulating cyclic AMP levels in T cells. Eur J Immunol 18: 961-964;1988.
8. Chen D, Rothenberg EV. Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinational transcription roles. J Exp Med 179:931-942;1994.
9. Cifone MG, Maria RD, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 177:1547-1552;1993.
10. Clements JL, Cooper SM, Budd RC. Abnormal regulation of the IL-2 promoter in lpr CD4-CD8- T lymphocytes results in constitutive expression of a novel nuclear factor of activated T cell-binding factor. J Immunol 154: 6372-6381;1995.
11. Cohen PL, Eisenberg RA. Lpr and gld. Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269;1991.
12. Fields PE, Gajewski TF, Fitch FW. Blocked Ras activation in anergic CD4+ T cells. Science 271:1276-1278;1996.
13. Garrity PA, Chen D, Rothenberg EV, Wold BJ. Interleukin-2 transcription is regulated in vitro at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Biol 14:2159-2169;1994.
14. + double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. J Immunol 151:597-609;1993.
15. Go C, Miller J. Differential induction of transcriptional factors that regulate the interleukin-2 gene during anergy induction and restimulation. J Exp Med 175:1327-1336;1992.
16. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D. Fas-induced apoptosis is mediated by a ceramide-initiated Ras signalling pathway. Immunity 2:341 -351;1995.
17. Hahn WC, Rosenstein Y, Burakoff SJ, Bierer BE. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induced adenosine 3′,5′-cyclic monophosphate production in T lymphocytes. J Immunol 147:14-21; 1991.
18. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that bind and potentiate the c-Jun activation domain. Genes Dev 7:2135-2148;1993.
19. Hsueh YP, Lai MZ. JNK but not MAP kinase is sensitive to cAMP in T lymphocytes. J Biol Chem 270:18094-18098;1995.
20. Hsueh YP, Liang HE, Ng SY, Lai MZ. CD28 costimulation activates CREB in T lymphocytes. J Immunol 158:85-93;1997.
21. Hsueh YP, Lai MZ. Overexpression of activated transcriptional factor I in lymphomas and in activated lymphocytes. J Immunol 154: 5675-5683:1995.
22. Jain J, Valge-Archer VE, Sinskey AJ, Rao A. The AP-1 site at -150 bp, but not the NT-κB site, is likely to represent the major target of protein kinase C in interleukin-2 promoter. J Exp Med 175:853-862;1992.
23. Kang SM, Beverly B, Tran AC, Brorson K, Schwanz RH, Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134-1138;1992.
24. Katagiri K, Katagiri T, Eisenberg RA, Ting J, Cohen PL. Interleukin-2 responses of lpr and normal L3T4/Lyt-2 T cells induced by TPA plus A23187. J Immunol 138:149-156;1987.
25. fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder. Proc Natl Acad Sci USA 86:10064-10068; 1989.
26. Lai MZ, Jang YJ, Chen LK, Gefter ML. T cell receptor V(D)J junctional diversity in the response specific for λ repressor: Selection of a highly restricted junctional element. J Immunol 144:4851-4856;1990.
27. Lee MR, Chung CS, Liou ML, Wu M, Li WF, Hsueh YP, Lai MZ. Isolation and characterization of nuclear proteins that bind to T cell receptor Vβ decamer motif. J Immunol 148: 1906-1912;1992.
28. Lee MR, Liou ML, Liou ML, Yang YF, Lai MZ. cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. J Immunol 151:5208-5217;1993.
29. Li W, Whaley CD, Mondino A, Mueller DL. Blocked signal transduction to the ERK and INK protein kinases in anergic CD4+ T cells. Science 271:1272-1276;1996.
30. Marais R, Wynne J, Treisman R, The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393;1993.
31. Meyer CF, Wang X, Chang C, Templeton D, Tan TH. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating B enhancer activation. J Biol Chem 271:8971-8976;1996.
32. Morse HC III, Davidson WF, Yetter RA, Murphy ED, Roths JB, Coffman RL. Abnormalities induced by the mutant gene lpr: expression of a unique lymphocyte subset. J Immunol 129: 2612-2618;1982.
33. Mountz JD, Steinberg AD, Klinman DM, Smith HR. Autoimmunity and increased c-myb transcription. Science 226:1087-1089; 1984.
34. Mueller DL, Jenkins MK. Molecular mechanism underlying functional T-cell unresponsiveness. Curr Opin Immunol 7:375-381; 1995.
35. Nagata S. Apoptosis by death factor. Cell 88: 355-365;1997.
36. Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza Jr BR, Serfling E. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14:1991-2004;1995.
37. ras during T-cell activation and growth. Immunol Today 16:159-165; 1995.
38. Rooney JW, Sun YL, Glimcher LH, Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 15:6299-6310;1995.
39. Samelson LE, Davidson WF, Morse III HC, Klausner RD. Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorder. Nature 324:674-676;1986.
40. Seder RA, Paul WE. Acquisition of lymphokine-production phenotype by CD4 T cells. Annu Rev Immunol 12:635-673;1994.
41. Shaw J, Meerovitch K, Bleackley RC, Paetkau V. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J Immunol 140: 2243-2248;1988.
42. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Nerian Y. JNK is involved in signal transduction during costimulalion of T lymphocytes. Cell 77:727-736;1994.
43. Umlauf SW, Beverly B, Lantz O, Schwanz RH. Regulation of interieukin-2 gene expression by CD2S costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNAs are regulated with complex kinetics. Mol Cell Biol 15: 3197-3205;1995.
44. van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 37:1305-1310;1994.
45. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317;1992.
46. Whitehurst CE, Geppert TD. MEK1 and the extracellular signal-regulated kinase are required for the stimulation of IL-2 gene transcription in T cells. J Immunol 156:1020-1029;1996.
47. Wofsy D, Hardy RR, Seaman WE. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on 'helper' T cells that is involved in the response of class II major histocompatibility antigens. J Immunol 132:2686-2689;1984.
48. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-468;1993.
49. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with receptor of tumor necrosis factor. J Exp Med 169:1747-1756;1989.